| Natalie Rose Woods, PTA | |
|
603 N Progress Ave, Siloam Springs, AR 72761-4352 | |
| (479) 215-3000 | |
| Not Available |
| Full Name | Natalie Rose Woods |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy Assistant |
| Location | 603 N Progress Ave, Siloam Springs, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770254146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 4703 (Arkansas) | Secondary |
| 225200000X | Physical Therapy Assistant | 4703 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Natalie Rose Woods, PTA 10 Ettington Dr, Bella Vista, AR 72714-3201 Ph: (479) 866-2501 | Natalie Rose Woods, PTA 603 N Progress Ave, Siloam Springs, AR 72761-4352 Ph: (479) 215-3000 |
News Archive
Researchers from the Universitat Oberta de Catalunya (UOC) and the technology centre Eurecat have developed an innovative formal representation of rare disease data, including information unavailable in current models on the rare disease patient's biological, psychological and social profile.
Whether a child is conceived naturally or in a Petri dish in an incubator has no bearing at all on the child's mental health. However, researchers have identified a small but increased risk of developing a mental disorder such as autism, ADHD or behavioural problems in children whose mothers only received medical treatment to stimulate ovulation and egg development before insemination.
Myriad Genetics, Inc. today announced a significant improvement in the sample collection kit for OnDoseTM, its 5-Fluorouracil (5-FU) dose optimization product. Patient sample handling can now be conducted at room temperature, eliminating the need for frozen sample handling. Myriad said that it believes the simplified process should increase physician acceptance and utilization of OnDose.
Claritas Genomics will present data on the quality of parallel multi-technology sequencing, a comparison of the company's phenotypically driven Pediatric Neurology Exome Assay to whole exome and panel-based approaches, three-part reports for rapid results reporting, and the clinical utility of the Neurology Exome's tailored approach compared to other tests currently on the market.
The European Society of Clinical Microbiology and Infectious Disease – an organization that explores the risks and best practices in infectious disease – takes the opportunity ahead of the European Antibiotic Awareness Day on 18 November to highlight two of the society's more recent projects in the fight against antimicrobial resistance.
› Verified 4 days ago